ICS use maintains RNFL rate

Article

Intranasal corticosteroids (ICS) maintain retinal nerve fibre layer (RNFL) thickness and optic nerve cup to disc ratio among patients with glaucoma or glaucoma suspect.

Intranasal corticosteroids (ICS) maintains retinal nerve fibre layer (RNFL) thickness and optic nerve cup to disc ratio among patients with glaucoma or glaucoma suspect.

Dr Johnson and his team, Neuro-Ophthalmology Unit, Mason Eye Institute, included 170 glaucoma or glaucoma suspect patients in a retrospective study. The rates of change in RNFL thickness and fast optic disc scan data were compared between ICS users and non-ICS users.

The results revealed there were no significant differences in superior, nasal, inferior and temporal RNFL thickness between ICL users and non-users. There was also no significant difference between the groups in horizontal and vertical cup to disc ratio.

Short-term ICS use presented no significant differences in both optic to cup disc ratio and RNFL thickness in glaucoma or glaucoma suspects.

The abstract was recently published in the European Journal of Ophthalmology.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.